Montérégie Integrated Cancer Center in Quebec, Canada, part of Charles-LeMoyne Hospital, is the first center in the country to treat cancer patients using Accuray's Radixact radiation therapy delivery system.
A second Radixact system is scheduled to be installed at the center later in 2024. The system at the Montérégie center also incorporates the Accuray exclusive ClearRT helical fan-beam kVCT imaging solution and Synchrony motion adaptation technology. Combined, this allows for clinicians to acquire diagnostic-like quality CT images along with tracking, detecting, and correcting for tumor movement in real-time, the company said.
The Radixact system provides a non-invasive option for treating a range of cancerous and noncancerous tumors throughout the body. It can be used in combination with surgery, chemotherapy, and other medications. It also can be used for preconditioning regimens before bone marrow transplants.
